Oral Solution Quick Tips | See abbv.ie/RinvoqPI

Описание: Visit https://abbv.ie/RinvoqPI to see Full Prescribing Info & Medication Guide. Watch to learn more about the Uses and Important Safety Information for RINVOQ® (upadacitinib).

In this video you’ll learn how to give your child RINVOQ LQ while understanding the importance of building a routine and how you could get support.

Discover how to make RINVOQ part of your daily routine: https://abbv.ie/RoutineBuilder

USES
RINVOQ/RINVOQ LQ is a prescription medicine used to treat:
• Children 2 years of age and older with active polyarticular juvenile idiopathic arthritis (pJIA) when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated.
• Children 2 to less than 18 years of age with active psoriatic arthritis (PsA) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
It is not known if RINVOQ/RINVOQ LQ is safe and effective in children under 2 years of age with with polyarticular juvenile idiopathic arthritis (pJIA) or psoriatic arthritis.

Safety Considerations for RINVOQ/RINVOQ LQ (upadacitinib)
RINVOQ* may cause serious side effects, including:
• Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
• Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
• Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
• Increased risk of major cardiovascular events, such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
• Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
• Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
• Tears in the stomach or intestines; changes in certain laboratory test results.
*Unless otherwise stated, "RINVOQ" in the Safety Considerations refers to RINVOQ and RINVOQ LQ.

Please see additional Important Safety Information here: https://abbv.ie/RinvoqISI

Learn more at: https://www.RINVOQ.com

0:00 – 0:22 Please see Prescribing Information, Instructions for Use, and Safety Information
0:23 – 2:20 Uses and Safety Considerations
2:21 – 2:59 Giving Your Child RINVOQ LQ
3:00 – 4:07 Preparing and Administering RINVOQ LQ
4:08 – 4:26 Building a Daily Routine
4:27 – 4:59 Getting Support
5:00 – 15:49 Important Safety Information